XML 96 R77.htm IDEA: XBRL DOCUMENT v3.3.1.900
Selected Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Product sales, net $ 41,973 $ 41,986 $ 37,202 $ 33,168 $ 40,737 $ 33,621 $ 31,551 $ 26,064   $ 154,329 $ 131,973 $ 99,414
Promotion services revenue 890 894 744 400 688 666 962 501   2,928 2,817 27,644
Cost of product sales 5,217 6,853 5,681 4,597 7,425 6,005 5,011 4,561   22,348 23,002 17,668
Net income $ 12,544 $ 11,979 $ (4,022) $ 8,962 $ 3,519 $ 7,915 $ 9,640 $ 4,134   $ 29,463 $ 25,208 $ 10,964
Basic net income per share $ 0.25 $ 0.24 $ (0.08) $ 0.18 $ 0.07 $ 0.16 $ 0.19 $ 0.08   $ 0.59 $ 0.49 $ 0.20
Diluted net income per share $ 0.24 $ 0.23 $ (0.08) $ 0.17 $ 0.07 $ 0.15 $ 0.18 $ 0.08   $ 0.56 $ 0.48 $ 0.20
Upfront payments     $ 5,500   $ 11,000             $ 5,000
SEC settlement expense (Notes 18 and 22)     $ 10,800           $ 2,000 $ 10,826   $ 2,000
SEC settlement loss                   12,800    
Upfront and regulatory milestone payments $ 2,000                 $ 2,000    
Cardiome [Member]                        
Payment received for repurchased inventory 1,100                      
Reduction in general and administraive expense $ 300